Pnc Financial Services Group, Inc. Nautilus Biotechnology, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$2.34 - $3.39 $1,247 - $1,806	-533 Reduced 97.98%	11 $0
Q2 2023 Aug 11, 2023	SELL	$2.21 - $4.52 $216 - $442	-98 Reduced 15.26%	544 $2,000
Q4 2022 Feb 10, 2023	SELL	$1.55 - $2.47 $85 - $135	-55 Reduced 7.89%	642 $1,000
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.13 $107 - $172	55 Added 8.57%	697 $1,000
Q2 2022 Aug 12, 2022	BUY	$2.64 - $4.84 $1,694 - $3,107	642 New	642 $1,000
Q1 2022 May 12, 2022	SELL	$3.5 - $5.3 $10,500 - $15,900	-3,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.45 - $6.21 $13,350 - $18,630	3,000 New	3,000 $15,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $299M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.